Womens Health

FDA Approval for Surgical Robot with Humanoid Arms for Transvaginal Hysterectomies

No comments
FDA Approval for Surgical Robot with Humanoid Arms for Transvaginal Hysterectomies

Memic Innovative Surgery, a medical device company with headquarters in Israel and Florida, received FDA authorization to introduce the first of its kind robotic surgical system that utilizes humanoid-shaped arms to achieve impressive reach and procedural safety. It is intended for benign hysterectomies or the removal of the uterus for non-cancerous conditions along with the

iData ResearchFDA Approval for Surgical Robot with Humanoid Arms for Transvaginal Hysterectomies
read more

Can AI Help Improve In-Vitro Fertilization Rates?

No comments
Can AI Help Improve In-Vitro Fertilization Rates?

Although in vitro fertilization solely involves a sperm and an egg, the process leading to an embryo can be more challenging than just putting the two together. In 2019, the Centers for Disease Control and Prevention (CDC) reported that approximately 10% of women in the U.S. between the ages of 15-44 had difficulty either getting

iData ResearchCan AI Help Improve In-Vitro Fertilization Rates?
read more

Understanding the COVID-19 Impact on Sales of Medical Devices at the SKU Level

No comments
Understanding the COVID-19 Impact on Sales of Medical Devices at the SKU Level

Product managers are continuously looking for data and insights to support strategy and to find valuable market information. Companies in industries that are private and guarded find themselves in situations where their questions are usually longer and more complex than possible answers. In 2020 the emerging question is: “what is the impact of COVID-19 in

iData ResearchUnderstanding the COVID-19 Impact on Sales of Medical Devices at the SKU Level
read more

Can Major Gynecologic Cancer Surgeries Continue Safely in the COVID-19 Era?

No comments
Can Major Gynecologic Cancer Surgeries Continue Safely in the COVID-19 Era?

Gynecologic cancer or reproductive cancer refers to any part of the female reproductive system: cervical, ovarian, uterine, vaginal, and vulvar. The risk of gynecologic cancers increases with age. Like any other type of cancer, gynecology cancer is difficult to detect only by external symptoms; in some cases, early cancer may be detected during clinical exams

iData ResearchCan Major Gynecologic Cancer Surgeries Continue Safely in the COVID-19 Era?
read more

COVID-19’s Effect on the Immune System During Pregnancy

COVID-19’s Effect on the Immune System During Pregnancy

Much like during the initial outbreaks of other coronaviruses, there is little certainty regarding the exact effects of COVID-19, especially long-term. However, data about its effects on pregnant women is starting to accumulate and provide preliminary information and precautions. Both the acute and immediate effects of COVID-19 on the mother and child must be considered,

iData ResearchCOVID-19’s Effect on the Immune System During Pregnancy
read more

Astonishing 26.9% Decline of Pelvic Floor Repair Market due to FDA Recalls

Astonishing 26.9% Decline of Pelvic Floor Repair Market due to FDA Recalls

According to the recent market study by iData Research, the total Pelvic Floor Repair market in the U.S. will consequently decline at a -26.9% cumulative growth rate between the years of 2019-2026. The sharp decline is a result of FDA recalls for all transvaginal mesh devices along with a poor reputation of the sacrocolpopexy surgery.  Pelvic organ prolapse

iData ResearchAstonishing 26.9% Decline of Pelvic Floor Repair Market due to FDA Recalls
read more

Dexcom G6 CGM System Receives CE Mark for Use During Pregnancy

No comments
Dexcom G6 CGM System Receives CE Mark for Use During Pregnancy

Dexcom has announced that its G6 continuous glucose monitoring (CGM) system has won the CE Mark for use during pregnancy and will be available in the United Kingdom as soon as Spring 2020. During pregnancy, hormones that help the baby grow block the mother’s natural production of insulin and can cause insulin resistance. If insulin

iData ResearchDexcom G6 CGM System Receives CE Mark for Use During Pregnancy
read more

IMBiotechnologies Ekobi Microspheres Expanded

No comments
IMBiotechnologies Ekobi Microspheres Expanded

IMBiotechnologies Ltd, a medical device company located in Edmonton, Alberta, announced its latest approval from Health Canada. This approval has expanded the use of the organization’s product, the Ekobi Embolization Microspheres. This latest approval allows the microspheres to be used for treating uterine fibroids. IMB’s Ekobi utilizes a minimally invasive technique called embolotherapy, which blocks

iData ResearchIMBiotechnologies Ekobi Microspheres Expanded
read more

Social Trends in Birth Fostering Change in Gynecology

No comments
Social Trends in Birth Fostering Change in Gynecology

The U.S. market for gynecological devices is valued at almost $1.1 billion. Demographic factors, and age are just some of the driving forces that are facilitating change in the gynecology landscape. Assisted reproduction technologies (ART) help women or couples conceive children. Most couples who use ART are affected by infertility, although ART can also be

iData ResearchSocial Trends in Birth Fostering Change in Gynecology
read more

PATH and Sinapi Biomedical Launch Ellavi, a Lifesaving Medical Device to Combat Postpartum Hemorrhage

No comments
PATH and Sinapi Biomedical Launch Ellavi, a Lifesaving Medical Device to Combat Postpartum Hemorrhage

Register to receive a free U.S. Market Report Suite for Gynecological Devices report synopsis and brochure   PATH, a global healthcare organization, and Sinapi Biomedical, a company based in South Africa, have successfully launched Ellavi, the first commercially available, low-cost, fully assembled uterine balloon tamponade that has received internationally-recognized CE marking. In many developing countries, such as those in

iData ResearchPATH and Sinapi Biomedical Launch Ellavi, a Lifesaving Medical Device to Combat Postpartum Hemorrhage
read more